What is the price target for ANL stock?
6 analysts have analysed ANL and the average price target is 31.62 USD. This implies a price increase of 389.47% is expected in the next year compared to the current price of 6.46.
ADLAI NORTYE LTD-ADR (ANL) Forecast, Price Target & Analyst Ratings
NASDAQ:ANL • US00704R1095
Current stock price
6.46 USD
-0.29 (-4.3%)
At close:
6.58 USD
+0.12 (+1.86%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADLAI NORTYE LTD-ADR (ANL).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$31.62
Upside
+ 389.47%
From current price of $6.46 to mean target of $31.62, Based on 6 analyst forecasts
Low
$16.16
Median
$31.62
High
$48.30
Price Target Revisions
1 Month
181.82%
3 Months
244.44%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for ANL. The average price target is 31.62 USD. This implies a price increase of 389.47% is expected in the next year compared to the current price of 6.46.
The average price target has been revised upward by 244.44% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
ANL was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ANL.
In the previous month the buy percentage consensus was at a similar level.
ANL was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-13 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-06-02 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-04 | HC Wainwright & Co. | Initiate | Buy |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2023-10-24 | Cantor Fitzgerald | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 45.73M | N/A -100.00% | 5.05M | 10.151M | 101K -99.01% | 202K 100.00% | 281.29M 139,152.48% | 202K -99.93% | 81.406M 40,200.00% | 476.42M 485.24% | 375.62M -21.16% | |||
| EBITDA YoY % growth | -27.07M | -7.77M 71.30% | N/A -753.54% | N/A -6.04% | -64.64M 27.40% | -42.218M 17.31% | -48.278M -14.35% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.62M | -8.65M 68.68% | N/A -677.69% | -54.742M -7.85% | -64.64M 27.05% | -29.694M 43.90% | -46.561M -56.80% | -72.417M -55.53% | 161.8M 323.43% | -297.748M -284.02% | -297.647M 0.03% | 344.21M 215.64% | 246.44M -28.40% | |
| Operating Margin | N/A | -18.92% | N/A | -1,084.00% | N/A | -292.52% | -46,100.00% | -35,850.00% | 57.52% | -147,400.00% | -365.63% | 72.25% | 65.61% | |
| EPS YoY % growth | N/A | N/A | N/A | -2.93 | -0.89 69.66% | -0.30 66.48% | -0.26 13.56% | -0.43 -68.63% | 1.15 365.12% | -1.69 -246.49% | -1.66 1.80% | 2.42 246.34% | 1.73 -28.75% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
14.76%
EPS Next 5 Year
-13.67%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A